From: A laboratory data-based evaluation of the efficacy and safety of generic pravastatin sodium for long-term use
Long-term continued use
Discontinuation (long-term)
Patients (N)
556
39
Men/women (N)
224/332
18/21
Mean age (years)
68.8 ± 10.9
73.8 ± 11.8
Mean treatment duration (weeks)
177 ± 3.61
158 ± 3.54